Lataa...

Inhibitor for protein disulfide-isomerase family A member 3 enhances the antiproliferative effect of inhibitor for mechanistic target of rapamycin in liver cancer: An in vitro study on combination treatment with everolimus and 16F16

mTOR is involved in the proliferation of liver cancer. However, the clinical benefit of treatment with mTOR inhibitors for liver cancer is controversial. Protein disulfide isomerase A member 3 (PDIA3) is a chaperone protein, and it supports the assembly of mTOR complex 1 (mTORC1) and stabilizes sign...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncol Lett
Päätekijät: Kaneya, Yohei, Takata, Hideyuki, Wada, Ryuichi, Kure, Shoko, Ishino, Kousuke, Kudo, Mitsuhiro, Kondo, Ryota, Taniai, Nobuhiko, Ohashi, Ryuji, Yoshida, Hiroshi, Naito, Zenya
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: D.A. Spandidos 2021
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7681208/
https://ncbi.nlm.nih.gov/pubmed/33240434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.12289
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!